3 min read The GLP-1 landscape changed on 1 April 2026, when the FDA approved Eli Lilly's orforglipron under the brand name Foundayo as the first non-peptide, small-molecule GLP-1 receptor agonist (GLP-1RA) anywhere in the world
Anti-aging and wrinkle prevention For anti-aging , evening application is definitively superior
Jojoba Esters A nourishing film-forming emollient with soothing properties that hydrates the skin while supporting the skin barrier
Discontinuation, cost, invasiveness, and individual clinical circumstances all shape which option actually fits a given patient
Data of most crystals were limited to 10 because of radiation damage and only two crystals were collected to 180
From initial labs to weekly follow-ups, treatment plans are adjusted based on your biology, medication response, and side effect profile